Novavax (NVAX) closed at $7.91 in the latest trading session, marking a -0.57% move from the prior day. The stock's change was less than the S&P 500's daily gain of 1.08%. On the other hand, the Dow ...

Vaccine Research Market Governments and private entities are heavily investing in vaccine research and development.US, NY, UNITED STA ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

BMC, a TMR-based vaccine manufacturer, has cancelled a contract with American biotech firm Novavax almost five years to the ...

Starting from April 8, people aged 65 and older, indigenous people aged 55 to 64, children younger than six months old and ...

Vermont has the second lowest state fatality rate in the US (146.3 per 100K; Hawaii 112.7/100K). Mississippi (462.8/100K) and ...

Shares of vaccine-maker Moderna MRNA closed at $34.71 on Monday, close to their 52-week low of $29.25. Moderna is facing several headwinds, including the declining COVID-19 vaccine and the soft sales ...

BioNTech is expanding its oncology pipeline with FixVac, iNeST, and BNT327 for individualized cancer treatments. Read why I ...

Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...

Moncef Slaoui, who ran the Operation Warp Speed Covid vaccine effort, is becoming chair of Curevo, a company developing a new ...

Improving our public health infrastructure so people once again trust science and expertise is essential before the next ...

Novavax performed well last year, but the company's shares are down significantly over the past three years and are not far ...